DOCSLIB.ORG

Targeting RGD-Binding Integrins As an Integrative Therapy for Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Targeting RGD-Binding Integrins As an Integrative Therapy for Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration Progress in Retinal and Eye Research xxx (xxxx) xxx Contents lists available at ScienceDirect Progress in Retinal and Eye Research journal homepage: www.elsevier.com/locate/preteyeres Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration Inge Van Hove a,1, Tjing-Tjing Hu a,1, Karen Beets a, Tine Van Bergen a, Isabelle Etienne a, Alan W. Stitt a,b,*, Elke Vermassen a, Jean H.M. Feyen a a Oxurion NV, Gaston Geenslaan 1, 3001, Heverlee, Belgium b Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Northern Ireland, UK ARTICLE INFO ABSTRACT Keywords: Integrins are a class of transmembrane receptors that are involved in a wide range of biological functions. RGD-binding integrin Dysregulation of integrins has been implicated in many pathological processes and consequently, they are Diabetic retinopathy attractive therapeutic targets. In the ophthalmology arena, there is extensive evidence suggesting that integrins Neovascular age-related macular degeneration play an important role in diabetic retinopathy (DR), age-related macular degeneration (AMD), glaucoma, dry eye Retina disease and retinal vein occlusion. For example, there is extensive evidence that arginyl-glycyl-aspartic acid (Arg- Gly-Asp; RGD)-binding integrins are involved in key disease hallmarks of DR and neovascular AMD (nvAMD), specificallyinflammation, vascular leakage, angiogenesis and fibrosis.Based on such evidence, drugs that engage integrin-linked pathways have received attention for their potential to block all these vision-threatening pathways. This review focuses on the pathophysiological role that RGD-binding integrins can have in complex multi­ factorial retinal disorders like DR, diabetic macular edema (DME) and nvAMD, which are leading causes of blindness in developed countries. Special emphasis will be given on how RGD-binding integrins can modulate the intricate molecular pathways and regulate the underlying pathological mechanisms. For instance, the interplay between integrins and key molecular players such as growth factors, cytokines and enzymes will be summarized. In addition, recent clinical advances linked to targeting RGD-binding integrins in the context of DME and nvAMD will be discussed alongside future potential for limiting progression of these diseases. proliferation and survival with clear linkage to pathological processes, including inflammation, vascular leakage, neovascularization and 1. Introduction fibrosis( Eklund et al., 2017; Fu et al., 2007; Hammes et al., 1996; Kanda et al., 2012; Koch and Distler, 2007; Santulli et al., 2008; Umeda et al., Integrin receptors are transmembrane heterodimeric adhesion pro­ 2006; Wilkinson-Berka et al., 2006; Zahn et al., 2009). The teins that play an essential role in integrating the extracellular to the multi-facetted role integrins play in cell pathophysiology is still being intracellular environment. In the mid-eighties, the firstintegrin receptor investigated and deciphering the precise nature of integrin-linked mo­ was discovered based on its engagement with specific motifs on extra­ lecular mechanisms in health and disease remains a significant and cellular matrix (ECM) protein fibronectin( Pierschbacher and Ruoslahti, relevant research challenge. 1984; Tamkun et al., 1986). Since then, a vast number of articles on In the last few years, there has been renewed interest in integrins and integrins have been published on a regular basis (on average ~2000 new especially drugs that target arginyl-glycyl-aspartic acid (Arg-Gly-Asp; publications per year and ~27,000 to date) and it is established that RGD) -binding integrins in tissues of the eye. This reinvigoration in the these receptors are involved in various cellular processes such as area has been driven, at least in part, by recent preclinical and clinical adhesion, differentiation, shape, migration, signalling, invasion, * Corresponding author. McCauley Chair of Experimental Ophthalmology, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK. E-mail addresses: [email protected] (I. Van Hove), [email protected] (T.-T. Hu), [email protected] (K. Beets), Tine.VanBergen@ oxurion.com (T. Van Bergen), [email protected] (I. Etienne), [email protected] (A.W. Stitt), [email protected] (E. Vermassen), Jean. [email protected] (J.H.M. Feyen). 1 These authors contributed equally to the work. https://doi.org/10.1016/j.preteyeres.2021.100966 Received 8 January 2021; Received in revised form 15 March 2021; Accepted 19 March 2021 Available online 26 March 2021 1350-9462/© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Please cite this article as: Inge Van Hove, Progress in Retinal and Eye Research, https://doi.org/10.1016/j.preteyeres.2021.100966 I. Van Hove et al. Progress in Retinal and Eye Research xxx (xxxx) xxx List of abbreviations IL Interleukin IPL Inner plexiform layer AMD Age-related macular degeneration IVT Intravitreal Ang Angiopoietin LAP Latency-associated peptide ANGPTL Angiopoietin-like protein MCP Monocyte chemoattractant protein BBB Blood-brain barrier MMP Matrix metalloproteinase BCVA Best corrected visual acuity nvAMD Neovascular age-related macular degeneration bFGF Basic fibroblast growth factor NF-κB Nuclear factor kappa B CAM Chick chorioallantoic membrane NLRP3 NACHT, LRR and PYD domains-containing protein 3 CNV Choroidal neovascularization PDR Proliferative diabetic retinopathy CST Central subfield thickness PI3K Phosphoinositide-3-kinase CTGF Connective tissue growth factor PlGF Placental growth factor DME Diabetic macular edema POS Photoreceptor outer segments DR Diabetic retinopathy RGC Retinal ganglion cell EC Endothelial cell RGD Arginyl-glycyl-aspartic acid ECM Extracellular matrix ROP Retinopathy of prematurity EGF Epidermal growth factor RPE Retinal pigment epithelial EMT Epithelial-to-mesenchymal transition SMA Smooth muscle actin EndoMT Endothelial-to-mesenchymal transition STZ Streptozotocin ERK Extracellular signal-regulated kinase TGF Transforming growth factor FAK Focal adhesion kinase TNF Tumour necrosis factor HUVEC Human umbilical vein endothelial cell uPA Urokinase-type plasminogen activator IGFBP Insulin-like growth factor-binding protein VEGF Vascular endothelial growth factor studies which demonstrated promising results in retinal diseases such as Reddy, 2012). Integrins are obligate heterodimeric receptors consisting diabetic retinopathy (DR), diabetic macular edema (DME) and neo­ of an α- and a β-subunit. Currently, 18 α-subunits and eight β-subunits vascular age-related macular degeneration (nvAMD) (Askew et al., are known, and various combinations thereof constitute the family of 24 2018; Shaw et al., 2020; Tolentino et al., 2016). The main goal of this heterodimeric integrin members (Humphries et al., 2006; Pan et al., review is to highlight preclinical as well as clinical knowledge on the 2016). The classification of the integrin receptor family into four role of mainly RGD-binding integrins in DR, DME, proliferative DR different classes is based on their structure similarity and ligand recog­ (PDR) and nvAMD. In addition, we will endeavour to provide compre­ nition pattern: 1) RGD-binding, 2) collagen-binding, 3) hensive information on the intricate cellular and molecular mechanisms leukocyte-specific and 4) laminin-binding integrin receptors (Fig. 1). of RGD-binding integrin signalling in the main disease hallmarks of The first subgroup recognizes the tripeptide sequence RGD in their these vision-threatening retinal disorders. natural ligands (e.g. fibronectin)and consists of eight different integrins: αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, αIIbβ3, α5β1 and α8β1. However, it is now 2. Classification and function of integrins known that RGD-binding integrins also bind to many other ECM proteins (e.g. vitronectin, fibrinogenand osteopontin) as well as growth factors, Integrins constitute a family of ubiquitously expressed trans­ cytokines, enzymes, bacterial proteins and hormones (LaFoya et al., membrane receptors that regulate cell-cell and cell-ECM interactions 2018; Ruoslahti, 1996; Wu and Reddy, 2012). (Bouvard et al., 2013; LaFoya et al., 2018; Moser et al., 2009; Wu and Integrin receptors are activated upon binding to their cognate Fig. 1. Classification of the integrin receptor family. 2 I. Van Hove et al. Progress in Retinal and Eye Research xxx (xxxx) xxx ligands. The affinity and activation state can be influenced by engage­ et al., 1990; Chu and Grunwald, 1991; Elner and Elner, 1996; Li et al., ment of intracellular proteins, such as talin and kindlin, to the integrin 2009). In chick and rat retina, adhesion of RPE cells to Bruch’s mem­ cytoplasmic domains. This outside-in and inside-out signalling enables brane was found to involve an integrin-fibronectin interaction (Philp integrins to 1) carry signals from the extracellular microenvironment and Nachmias, 1987). The apical microvilli of the RPE cells expressed and 2) respond to changes from inside the cell to induce a conforma­ αvβ5 which is essential for phagocytosis and internalization of the shed tional change and modulate their affinity for extracellular ligands POS-αvβ5 complex (Finnemann et al., 1997; Li et al., 2009; Lin and (Bouvard et al., 2013; Dalton et al., 2016; Klapholz and Brown, 2017). Clegg, 1998). Furthermore,
Load more

Recommended publications
  • Bilirubin Modulates Leukocyte Recruitment to Sites of Inflammation
    Bilirubin modulates leukocyte recruitment to sites of inflammation A dissertation presented by Megan Elizabeth Vogel B.S., Ohio University 2011 To The Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Internal Medicine, Division of Digestive Diseases of the College of Medicine March 2017 Committee Chair: Stephen D. Zucker, M.D. Abstract Background: Bilirubin is the principal end-product of heme catabolism. While generally thought to be little more than a metabolic by-product, there is accumulating epidemiological evidence that higher serum bilirubin levels are associated with a lower incidence of inflammatory disorders such as inflammatory bowel and cardiovascular disease. However, the mechanism(s) by which bilirubin may exert an anti-inflammatory effect remains poorly understood. The transendothelial migration of immune cells to sites of inflammation is a highly- ordered, multi-step process that is initiated when endothelial cells become activated to express adhesion molecules, including Vascular Cell Adhesion Molecule 1 (VCAM-1) and Intercellular Adhesion Molecule 1 (ICAM-1), on their luminal surface. The specific binding of leukocyte integrins to VCAM-1 and/or ICAM-1 triggers endothelial signaling cascades that result in the intracellular generation of superoxide and hydrogen peroxide. These reactive oxygen species (ROS) induce reorganization of the actin cytoskeleton, promoting leukocyte transmigration. There are many disease states in which VCAM-1 and ICAM-1 are believed to play an essential pathogenic role in mediating leukocyte trafficking. As bilirubin is a potent, chain-breaking antioxidant, our central hypothesis is that it exerts an anti-inflammatory effect by disrupting adhesion molecule-mediated leukocyte migration through the scavenging of ROS signaling intermediaries.
    [Show full text]
  • Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling
    Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling This information is current as Yoko K. Takada, Jessica Yu, Michiko Shimoda and of October 2, 2021. Yoshikazu Takada J Immunol published online 22 July 2019 http://www.jimmunol.org/content/early/2019/07/19/jimmun ol.1801630 Downloaded from Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 2, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 22, 2019, doi:10.4049/jimmunol.1801630 The Journal of Immunology Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling Yoko K. Takada,*,† Jessica Yu,* Michiko Shimoda,* and Yoshikazu Takada*,† CD40L plays a major role in immune response and is a major therapeutic target for inflammation. Integrin a5b1 and CD40 simultaneously bind to CD40L. It is unclear if a5b1 and CD40 work together in CD40/CD40L signaling or how a5b1 binds to CD40L.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Silencing of ITGB6 Inhibits the Progression of Cervical Carcinoma Via Regulating JAK/STAT3 Signaling Pathway
    803 Original Article Page 1 of 12 Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway Xiaoxia Zheng, Yanan Zhu, Xiaoping Wang, Yanmei Hou, Yingji Fang Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University/Jinan Maternity and Child Care Hospital Affiliated, Jinan, China Contributions: (I) Conception and design: Y Fang; (II) Administrative support: Y Hou; (III) Provision of study materials or patients: X Zheng, Y Zhu, X Wang; (IV) Collection and assembly of data: X Zheng, Y Zhu, X Wang; (V) Data analysis and interpretation: X Zheng, Y Zhu, X Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Yingji Fang. Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University/Jinan Maternity and Child Care Hospital Affiliated, No. 2 Jianguo Xiaojingsan Road, Jinan 250001, China. Email:[email protected] . Background: Integrin β6 (ITGB6), a key submonomer of integrin αvβ6, plays an important role in epithelial-to-mesenchymal transition (EMT), wound healing, epithelial-derived tumor growth, fibrosis, and epithelial repair. However, the role of ITGB6 in cervical carcinoma (CC) remains elusive. Methods: The expression levels of ITGB6 in CC tissues and cell lines were determined using quantitative real-time polymerase chain reaction (qRT-PCR). The cell viability, proliferation, apoptosis, migration, and invasion were evaluated by Cell Counting Kit-8 (CCK-8), colony-forming, flow cytometry, and Transwell assay, respectively. The expression of related proteins, including EMT markers and the Janus kinase/signal transducer and activator of transcription (JAK/STAT3) signaling markers, were detected using western blotting.
    [Show full text]
  • Integrin Β6 Serves As an Immunohistochemical Marker For
    www.nature.com/scientificreports OPEN Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and Received: 21 April 2016 Accepted: 29 June 2016 promotes cell invasiveness in Published: 21 July 2016 cholangiocarcinoma Zequn Li1,2, Siddhartha Biswas1,2, Benjia Liang1,2, Xueqing Zou1,2, Liqun Shan1,2, Yang Li1,2, Ruliang Fang1 & Jun Niu1 Cholangiocarcinoma is a devastating malignancy that is notoriously difficult to diagnose and is associated with a high mortality. Despite extensive efforts to improve the diagnosis and treatment of this neoplasm, limited progress has been made. Integrin β6 is a subtype of integrin that is expressed exclusively on the surfaces of epithelial cells and is associated with a variety of tumors. In the present study, we investigated the expression and roles of integrin β6 in cholangiocarcinoma. β6 upregulation in cholangiocarcinoma was correlated with lymph node metastasis and distant metastasis. Moreover, integrin β6 was identified as a biomarker for the diagnosis of cholangiocarcinoma and an indicator of lymph node metastasis. Integrin β6 significantly promoted the proliferation, migration and invasion of cholangiocarcinoma cells. Furthermore, integrin β6 increased Rac1-GTPase, resulting in the upregulation of metalloproteinase-9 (MMP9) and F-actin polymerization. Taken together, our results indicate that integrin β6 promotes tumor invasiveness in a Rac1-dependent manner and is a potential biomarker for tumor metastasis. Integrin β6 may help to improve the diagnostic accuracy, and targeting β6 may be a novel strategy for the treatment of cholangiocarcinoma. Cholangiocarcinoma is neoplasm originating from the ductular epithelium of the biliary tree, either within the liver (intrahepatic cholangiocarcinoma) or more commonly from the extrahepatic bile ducts (extrahepatic cholan- giocarcinoma).
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Cell Adhesion Molecules in Normal Skin and Melanoma
    biomolecules Review Cell Adhesion Molecules in Normal Skin and Melanoma Cian D’Arcy and Christina Kiel * Systems Biology Ireland & UCD Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +353-1-716-6344 Abstract: Cell adhesion molecules (CAMs) of the cadherin, integrin, immunoglobulin, and selectin protein families are indispensable for the formation and maintenance of multicellular tissues, espe- cially epithelia. In the epidermis, they are involved in cell–cell contacts and in cellular interactions with the extracellular matrix (ECM), thereby contributing to the structural integrity and barrier for- mation of the skin. Bulk and single cell RNA sequencing data show that >170 CAMs are expressed in the healthy human skin, with high expression levels in melanocytes, keratinocytes, endothelial, and smooth muscle cells. Alterations in expression levels of CAMs are involved in melanoma propagation, interaction with the microenvironment, and metastasis. Recent mechanistic analyses together with protein and gene expression data provide a better picture of the role of CAMs in the context of skin physiology and melanoma. Here, we review progress in the field and discuss molecular mechanisms in light of gene expression profiles, including recent single cell RNA expression information. We highlight key adhesion molecules in melanoma, which can guide the identification of pathways and Citation: D’Arcy, C.; Kiel, C. Cell strategies for novel anti-melanoma therapies. Adhesion Molecules in Normal Skin and Melanoma. Biomolecules 2021, 11, Keywords: cadherins; GTEx consortium; Human Protein Atlas; integrins; melanocytes; single cell 1213. https://doi.org/10.3390/ RNA sequencing; selectins; tumour microenvironment biom11081213 Academic Editor: Sang-Han Lee 1.
    [Show full text]
  • ID AKI Vs Control Fold Change P Value Symbol Entrez Gene Name *In
    ID AKI vs control P value Symbol Entrez Gene Name *In case of multiple probesets per gene, one with the highest fold change was selected. Fold Change 208083_s_at 7.88 0.000932 ITGB6 integrin, beta 6 202376_at 6.12 0.000518 SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 1553575_at 5.62 0.0033 MT-ND6 NADH dehydrogenase, subunit 6 (complex I) 212768_s_at 5.50 0.000896 OLFM4 olfactomedin 4 206157_at 5.26 0.00177 PTX3 pentraxin 3, long 212531_at 4.26 0.00405 LCN2 lipocalin 2 215646_s_at 4.13 0.00408 VCAN versican 202018_s_at 4.12 0.0318 LTF lactotransferrin 203021_at 4.05 0.0129 SLPI secretory leukocyte peptidase inhibitor 222486_s_at 4.03 0.000329 ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 1552439_s_at 3.82 0.000714 MEGF11 multiple EGF-like-domains 11 210602_s_at 3.74 0.000408 CDH6 cadherin 6, type 2, K-cadherin (fetal kidney) 229947_at 3.62 0.00843 PI15 peptidase inhibitor 15 204006_s_at 3.39 0.00241 FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 202238_s_at 3.29 0.00492 NNMT nicotinamide N-methyltransferase 202917_s_at 3.20 0.00369 S100A8 S100 calcium binding protein A8 215223_s_at 3.17 0.000516 SOD2 superoxide dismutase 2, mitochondrial 204627_s_at 3.04 0.00619 ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 223217_s_at 2.99 0.00397 NFKBIZ nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta 231067_s_at 2.97 0.00681 AKAP12 A kinase (PRKA) anchor protein 12 224917_at 2.94 0.00256 VMP1/ mir-21likely ortholog
    [Show full text]
  • Anti-ITGB1 Monoclonal Antibody, Clone 4C7 (DCABH-1896) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-ITGB1 monoclonal antibody, clone 4C7 (DCABH-1896) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Mouse monoclonal to Integrin beta 1 Antigen Description Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands.
    [Show full text]
  • Stat3beta, a Distinct Isoform from STAT3
    International Journal of Biochemistry and Cell Biology 110 (2019) 130–139 Contents lists available at ScienceDirect International Journal of Biochemistry and Cell Biology journal homepage: www.elsevier.com/locate/biocel STAT3beta, a distinct isoform from STAT3 T ⁎⁎ ⁎ Hui-Xiang Zhanga,b, Ping-Lian Yanga,b, En-Min Lia,c, , Li-Yan Xua,b, a The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou 515041, Guangdong, PR China b Institute of Oncological Pathology, Shantou University Medical College, Shantou, Guangdong, PR China c Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, Guangdong, PR China ARTICLE INFO ABSTRACT Keywords: STAT3β is an isoform of STAT3 (signal transducer and activator of transcription 3) that differs from the STAT3α STAT3 isoform by the replacement of the C-terminal 55 amino acid residues with 7 specific residues. The constitutive STAT3β activation of STAT3α plays a pivotal role in the activation of oncogenic pathways, such as cell proliferation, JAK/STAT3 pathway maturation and survival, while STAT3β is often referred to as a dominant-negative regulator of cancer. STAT3β Cancer suppressor reveals a “spongy cushion” effect through its cooperation with STAT3α or forms a ternary complex with other Prognostic factor co-activators. Especially in tumour cells, relatively high levels of STAT3β lead to some favourable changes. However, there are still many mechanisms that have not been clearly explained in contrast to STAT3α, such as STAT3β nuclear retention, more stable heterodimers and the prolonged Y705 phosphorylation. In addition to its transcriptional activities, STAT3β may also function in the cytosol with respect to the mitochondria, cytoske- leton rearrangements and metastasis of cancer cells.
    [Show full text]
  • Review Integrins: Bidirectional, Allosteric Signaling Machines
    Cell, Vol. 110, 673–687, September 20, 2002, Copyright 2002 by Cell Press Integrins: Bidirectional, Review Allosteric Signaling Machines Richard O. Hynes1 and Hynes, 2002). The simplest metazoa, sponges and Howard Hughes Medical Institute cnidaria, have integrins (Burke, 1999; Hughes, 2001) and Center for Cancer Research it is clear that primitive bilateria had at least two integrin Department of Biology ␣␤ heterodimers, the descendents of which persist to Massachusetts Institute of Technology this day in organisms as diverse as flies, nematodes, Cambridge, Massachusetts 02139 and vertebrates (Hynes and Zhao, 2000). Indeed, that is the entire set of integrins in Caenorhabditis elegans; one ␤ subunit and two ␣ subunits forming two integrins. In their roles as major adhesion receptors, integrins Orthologs of these two integrins are recognized in Dro- signal across the plasma membrane in both directions. sophila melanogaster and in vertebrates, although ver- Recent structural and cell biological data suggest tebrates have expanded each set (Figure 1). One set models for how integrins transmit signals between (blue in Figure 1) recognizes the tripeptide sequence, their extracellular ligand binding adhesion sites and RGD, in molecules such as fibronectin and vitronectin their cytoplasmic domains, which link to the cytoskel- in vertebrates and tiggrin in Drosophila, whereas the eton and to signal transduction pathways. Long-range other set (purple in Figure 1) mediates adhesion to base- conformational changes couple these functions via ment membrane laminins. It is plausible that evolution allosteric equilibria. of integrins was necessary to allow the cell-matrix adhe- sion intrinsic to metazoa, and as diploblastic organisms Integrins are the major metazoan receptors for cell adhe- evolved, the two cell layers may have evolved separate sion to extracellular matrix proteins and, in vertebrates, integrins to mediate their asymmetric interactions with also play important roles in certain cell-cell adhesions.
    [Show full text]
  • Molecular Update and Evolving Classification of Large B-Cell Lymphoma
    cancers Review Molecular Update and Evolving Classification of Large B-Cell Lymphoma Arantza Onaindia 1,2,*, Nancy Santiago-Quispe 2, Erika Iglesias-Martinez 2 and Cristina Romero-Abrio 2 1 Bioaraba Health Research Institute, Oncohaematology Research Group, 01070 Vitoria-Gasteiz, Spain 2 Osakidetza Basque Health Service, Araba University Hospital, Pathology Department, 01070 Vitoria-Gasteiz, Spain; [email protected] (N.S.-Q.); [email protected] (E.I.-M.); [email protected] (C.R.-A.) * Correspondence: [email protected]; Tel.: +34-699-639-645 Simple Summary: The development of high-throughput technologies in recent years has increased our understanding of the molecular complexity of lymphomas, providing new insights into the pathogenesis of large B-cell neoplasms and identifying different molecular biomarkers with prog- nostic impact, that lead to the revision of the World Health Organization consensus classification of lymphomas. This review addresses the main histopathological and molecular features of large B-cells lymphomas, providing an overview of the main recent novelties introduced by the last update of the consensus classification. Abstract: Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with consid- erable clinical, biologic, and pathologic diversity. The application of high throughput technologies to the study of lymphomas has yielded abundant molecular data leading to the identification of Citation: Onaindia, A.; distinct molecular identities and novel pathogenetic pathways. In light of this new information, Santiago-Quispe, N.; newly refined diagnostic criteria have been established in the fourth edition of the World Health Iglesias-Martinez, E.; Romero-Abrio, Organization (WHO) consensus classification of lymphomas, which was revised in 2016.
    [Show full text]